Cancer

Method AI Raises $20M in Series A Financing to Enhance Physician Visualization During Surgical Oncology Procedures

New funding to support building image-guided surgical navigation platformBOSTON--(BUSINESS WIRE)--Method AI, a medical technology company focused on improving oncology outcomes…

4 months ago

Method AI Raises $20M in Series A Financing to Enhance Physician Visualization During Surgical Oncology Procedures

New funding to support building image-guided surgical navigation platformBOSTON--(BUSINESS WIRE)--Method AI, a medical technology company focused on improving oncology outcomes…

4 months ago

Leaders Come Together to Advance the Industry at Veeva Summit

Alnylam Pharmaceuticals, BeOne Medicines, Intercept Pharmaceuticals, Merck, Pfizer, and Sanofi among biopharmas sharing strategies that set future direction Veeva to…

4 months ago

IgniteData Appoints Dr. David Rhew, Global Chief Medical Officer of Microsoft, to Board of Directors

NEW CASTLE, Del., Aug. 21, 2025 /PRNewswire/ -- IgniteData, a leader in intelligent clinical trial data automation, is proud to announce…

4 months ago

ISPOR’s Oncology and Statistical Methods Special Interest Groups Selects DistillerSR for Joint Systematic Review Project

Leading Pharmaceutical Manufacturers, Contract Research Organizations, and Academic Medical Centers Collaborate on Global Research Project Using DistillerSR. OTTAWA, ONTARIO /…

4 months ago

iTolerance, Inc. Appoints Former Chief of the Laboratory of Biochemistry in the FDA’s Center for Drug Evaluation and Research (CDER), Emily Shacter, Ph.D., to its Scientific Advisory Board

Esteemed expert in the regulation and development of biopharmaceuticals, with more than three decades of experience spanning government, industry, and…

4 months ago

Jaguar Health Participating in August 25-26 Animal Health Summit with Goal of Securing Collaboration to Expand Canalevia’s Indication to Treatment of General Diarrhea in Dogs

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia®-CA1, is conditionally approved by the FDA for treatment of CID in dogsCompany…

4 months ago

Global Healthcare Innovator Qure.ai Expands Executive Team With Eminent Lung Health Appointment to Accelerate Clinical Strategy

Dr. Javier J. Zulueta enters boardroom as Chief Medical Officer, Pulmonology, with potential of changing the lung cancer survival curve…

4 months ago

Molecular You Secures US$5 Million Series A to Scale its Predictive Health Platform

With one easy blood test, Molecular You measures over 250 biomarkers, enabling more powerful and comprehensive insights for preventive and…

4 months ago